Tirzepatide Reconstitution Math: Vial Sizes, BAC Water Volumes & Syringe Units

Tirzepatide is a dual GLP-1/GIP receptor agonist approved under the brand name Mounjaro for type 2 diabetes and Zepbound for chronic weight management. Compounded and research-grade tirzepatide is supplied as lyophilized powder in vials that must be reconstituted before use. Getting the math right is not optional — a calculation error directly translates to an incorrect dose. This guide walks through every step with worked examples.

Vial Sizes and Dose Progression

Compounded tirzepatide vials are commonly supplied in 5 mg, 10 mg, and 15 mg quantities. The FDA-approved titration schedule for Zepbound begins at 2.5 mg/week for four weeks, then advances in 2.5 mg increments every four weeks as tolerated: 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg/week. Matching the reconstitution volume to the target dose determines how many units to draw on a syringe.

Choosing a BAC Water Volume

The volume of bacteriostatic water (BAC water) added to the vial determines the resulting concentration (mg/mL) and therefore the number of units to inject. Common reconstitution volumes and the concentrations they produce are:

For a 10 mg vial: Add 1.0 mL BAC water → 10 mg/mL concentration. Add 2.0 mL BAC water → 5 mg/mL concentration. Add 4.0 mL BAC water → 2.5 mg/mL concentration.

Lower concentration (more water) means drawing more volume per dose, which makes measuring small doses easier and reduces the risk of measurement error on a syringe. Higher concentration (less water) means smaller injection volumes, which can reduce injection-site discomfort but demands more precise syringe reading.

How to Read a U-100 Insulin Syringe

U-100 syringes are calibrated so that 100 units equals 1.0 mL (1 cc). Every 10 units on the barrel equals 0.10 mL. This makes conversion straightforward: multiply the desired volume in mL by 100 to get units. For example, 0.5 mL = 50 units; 0.25 mL = 25 units.

Worked example: You have a 10 mg vial reconstituted with 2.0 mL of BAC water. Concentration = 10 mg / 2.0 mL = 5 mg/mL. Target dose = 5 mg/week. Volume needed = 5 mg ÷ 5 mg/mL = 1.0 mL = 100 units on a U-100 syringe. Another example: target dose = 2.5 mg/week from the same vial. Volume = 2.5 ÷ 5 = 0.5 mL = 50 units.

Pen vs. Syringe: Trade-offs

Brand-name Mounjaro and Zepbound use proprietary auto-injector pens with pre-set doses — no math required, no reconstitution, and needle exposure is minimized. Compounded tirzepatide supplied as vials requires the user to reconstitute, calculate, draw, and inject manually. The syringe approach allows dose flexibility (you can dial in any dose between 2.5 and 15 mg), but introduces calculation risk. The pen approach eliminates calculation error but is not available for compounded product.

For researchers or patients using compounded tirzepatide, best practices include: writing down the calculation before drawing, double-checking the concentration label on the vial, using a 1 mL syringe for doses under 1 mL to maximize precision, and never re-using syringes between injections.

Reconstitution Step-by-Step

1. Wipe the vial stopper and BAC water vial with an alcohol swab and allow to dry. 2. Draw the target BAC water volume into a syringe (e.g., 2.0 mL for a 10 mg vial). 3. Inject the BAC water slowly down the side of the tirzepatide vial — do not aim the stream directly at the powder. 4. Gently swirl (do not shake) until fully dissolved. The solution should be clear and colorless. 5. Label the vial with peptide name, concentration (mg/mL), reconstitution date, and calculated expiry (28 days from reconstitution). 6. Store refrigerated at 2–8°C. 7. Use our label-maker tool at /tools/label-maker to generate a printable vial label.